Skip to content

The Correlation and Intervention of Intestinal Flora and Frailty in the Elderly

The Correlation and Intervention of Intestinal Flora and Frailty in the Elderly

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03995342
Enrollment
300
Registered
2019-06-24
Start date
2019-08-01
Completion date
2024-12-31
Last updated
2024-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty Syndrome

Keywords

frailty, flora

Brief summary

The study aim to evaluate the improvement and correlation of soluble dietary fiber (prebiotics) in the frailty of elderly people by a randomized, double-blind, placebo-controlled clinical trial.

Detailed description

100 healthy controls, 100 pre-frailty and 100 frailty elderly will be included. the healthy controls will be received no intervention. The pre-frailty will be randomized at a 1:1 ratio to receive prebiotics (inulin) or placebo (maltodextrin) . The degree of improvements and correlation in frailty will be evaluated three months later.Similarly,the frailty also will be randomized at a 1:1 ratio to receive prebiotics (inulin) or placebo (maltodextrin). The degree of improvements and correlation in frailty will be evaluated three months later.

Interventions

DIETARY_SUPPLEMENTInulin

Inulin 15 grams after dissolution by mouth, every morning for three months.

DIETARY_SUPPLEMENTMaltodextrin

Placebo (maltodextrin) 15g/d,Oral administration after dissolution15g/d,Oral administration after dissolution

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥65 years; * Can get up from a chair and walk 6 meters * Clearly consciousness, able to read or use words to express and communicate without difficulty * Agree and accept the study plan

Exclusion criteria

* Acute and chronic inflammatory disease of the intestine within 3 months * Use of antibiotics, probiotics, prebiotics or synthetics, laxatives or diarrhea medications, proton pump inhibitors or gastric motility drugs within 1 month * Dementia * mental illness or blindness * acute infection * cancer

Design outcomes

Primary

MeasureTime frameDescription
Improvement of frailty3 monthsFrailty will be diagnosed according to Fried criteria

Secondary

MeasureTime frameDescription
Diversity analysis of intestinal flora3 monthsChange of diversity analysis of intestinal flora

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026